Compare AUTL & ORBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | ORBS |
|---|---|---|
| Founded | 2014 | 1966 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 373.9M |
| IPO Year | 2018 | N/A |
| Metric | AUTL | ORBS |
|---|---|---|
| Price | $1.42 | $1.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 2.1M | ★ 3.9M |
| Earning Date | 03-19-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $51,128,000.00 | $43,116,096.00 |
| Revenue This Year | $672.42 | N/A |
| Revenue Next Year | $84.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | 59.13 |
| 52 Week Low | $1.11 | $0.98 |
| 52 Week High | $2.70 | $83.12 |
| Indicator | AUTL | ORBS |
|---|---|---|
| Relative Strength Index (RSI) | 40.18 | 30.66 |
| Support Level | $1.31 | $1.17 |
| Resistance Level | $1.45 | $1.63 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 18.37 | 8.70 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.